Moderate and Severe Meibomiang Gland Dysfunction (Stage 3 or Stage 4 Meibomiang Gland Dysfunction)
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Changes of Keratometric Value and Ocular Aberration After Treatment of Meibomian Gland Dysfunction (NCT01692665) | Yonsei University | 2012-11-01 |
| Changes of Inflammatory Cytokines in the Tears of Moderate and Severe MGD Treated With Topical Loteprednol Etabonate (NCT01692652) | Yonsei University | 2012-08-01 |
Track Moderate and Severe Meibomiang Gland Dysfunction (Stage 3 or Stage 4 Meibomiang Gland Dysfunction) automatically
Every clearance here is in the API, with alerts when new ones post.